Abstract
A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
Original language | English |
---|---|
Pages (from-to) | 328-329 |
Number of pages | 2 |
Journal | Clinical Nuclear Medicine |
Volume | 33 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2008 |
Keywords
- metaiodobenzylguanidine (MIBG)
- medullary thyroid cancer
- phaeochromocytoma
- multiple endocrine neoplasia